SiriusPoint (SPNT) Q4 2025 earnings summary

Executive summary

• Achieved strong financial and operational performance in Q4 and full year 2025, with net income up 141% year-over-year to $444 million and book value per share rising 28%.

• Maintained disciplined underwriting, delivering a core combined ratio of 91.7% for the year and 92.9% for Q4, marking thirteen consecutive quarters of underwriting profit.

• Completed strategic sales of ArmadaCare and Arcadian MGAs, generating $390 million in liquidity and significant gains.

• Announced a $100 million share repurchase program and continued to optimize capital structure, reducing leverage to historic lows.

• Continued portfolio diversification, focusing on lower volatility and capital-light fee income streams.

Financial highlights

• Gross written premium grew 16% year-over-year to $3.7 billion for FY25; Q4 GWP up 18% to $897 million.

• Operating net income reached $310 million for FY25, with operating EPS of $2.55, up 49% year-over-year.

• Book value per diluted common share (ex. AOCI) rose 23.6% year-over-year to $18.10.

• Investment income for FY25 was $275 million, with 81% of the portfolio in investment-grade fixed income.

• Common shareholders' equity increased by $532 million to $2.3 billion.

Outlook and guidance

• Targets a 12–15% return on equity across the cycle, with FY25 operating ROE at 16.2%.

• Insurance segment combined ratio expected to remain around 91.7%-91.8% in 2026, with potential ±0.5 point variation.

• Fee income for 2026 expected to be around $30 million, with upside to $40 million+ after full integration of recent acquisitions in 2027.

• FY26 net investment income expected to be similar to FY25.

• $100 million share buyback planned over the next 12 months, expected to be accretive to EPS and ROE.